Safetek Announces New Life Sciences Direction


NEW YORK, May 23, 2005 (PRIMEZONE) -- On May 4, 2005, the Company (Pink Sheets:SFIN) resolved to focus on new technologies in the life sciences and health care fields. Despite the considerable medical advances that have occurred over the last few decades, there still remain major areas of unmet need. To date, Safetek has identified several innovative drug discovery, drug development and medical device technologies that may be used to create effective therapeutics for the treatment of various diseases.

About Safetek

Safetek Inc. intends to focus on development of new therapeutic compounds and/or medical device through in house development teams and sublicense research facilities. Safetek has also established an Israeli subsidiary to identify and further develop innovative technologies available in that region. Safetek plans to leverage these technologies to create an integrated therapeutic life science company.



            

Contact Data